TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
BNTC

Benitec Biopharma Ltd

Healthcare · Biotechnology

11.40$ +2.9% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Benitec Biopharma Ltd (BNTC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 53.0% of the shares are freely tradable; institutional investors hold 98.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 98.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 53.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 11.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 34Mio.

Largest Shareholders

Institutions

Institutions BNTC
Name Stake (%) Shares Change (%) Date
Suvretta Capital Management, LLC 33.62 11,548,351 +0.0 03/31/2026
HHG PLC 8.37 2,876,380 -1.2 03/31/2026
Franklin Templeton Inc 6.92 2,378,159 +8.2 03/31/2026
Adage Capital Partners Gp LLC 6.17 2,120,672 +0.0 06/30/2026
RA Capital Management, LLC 5.39 1,850,000 +0.0 03/31/2026
Nantahala Capital Management, LLC 4.19 1,438,371 +38.5 03/31/2026
BlackRock Inc 3.45 1,185,741 +19.5 03/31/2026
Simplify Asset Management Inc. 2.93 1,005,557 +78.8 06/30/2026

Funds

Funds BNTC
Name Stake (%) Shares Change (%) Date
HBM Healthcare Investments AG Ord 3.47 1,191,669 +0.0 06/30/2026
Simplify Health Care ETF 3.08 1,057,721 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?